SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EyeDrMike who wrote (18276)1/28/1999 6:22:00 PM
From: RealMuLan  Read Replies (1) of 23519
 
This post from Yahoo summerized the CC better:
<<
Conf Call Highlights
by: BritsOutofIreland (39/M/Jersey Shore) 25112 of 25125
Net Income +.03
Intl sales decreased
expenses lower
24 mill cash/cash equivilent
55% mkt share in Canada
US scripts flat
"It will be a challenge to be profitable in Q1 &Q2 due to slow regulatory approval" Leland
"no marketing partnership yet, on going talks with several Pharm Cos."
$ 8millon milestone due in 6months
Astra bought inventory for their pipeline in Q3 $ Q4. Therefore will not order in Q1.
Paine webber analyst Charlie O just served softballs for Leland
Dain Rauscher also questioned
Not one critical question asked.
>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext